19 phenotypes from 10 alleles in 11 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Gapdhem1(IMPC)Mbp/Gapdh+ C57BL/6N-Gapdhem1(IMPC)Mbp/MbpMmucd	abnormal blood vessel morphology	J:211773
	abnormal retina morphology	J:211773
	abnormal vitreous body morphology	J:211773
	cataract	J:211773
	embryonic growth retardation	J:211773
Gapdhem1(IMPC)Mbp/Gapdhem1(IMPC)Mbp C57BL/6N-Gapdhem1(IMPC)Mbp/MbpMmucd	embryonic lethality prior to organogenesis	J:211773
	preweaning lethality, complete penetrance	J:211773
Gapdhm1Neu/Gapdh+ C3.Cg-Gapdhm1Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
Gapdhm1Neu/Gapdh+ involves: 101/El * C3H/El	abnormal enzyme/coenzyme activity	J:15477
Gapdhm1Neu/Gapdhm1Neu C3.Cg-Gapdhm1Neu	embryonic lethality between implantation and somite formation, incomplete penetrance	J:126359
Gapdhm1Neu/Gapdhm1Neu involves: 101/El * C3H/El	preweaning lethality, complete penetrance	J:11216, J:15477
Gapdhm2Neu/Gapdh+ C3.Cg-Gapdhm2Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
Gapdhm2Neu/Gapdh+ involves: 101/El * C3H/El	abnormal enzyme/coenzyme activity	J:15476
Gapdhm2Neu/Gapdhm2Neu C3.Cg-Gapdhm2Neu	embryonic lethality between implantation and somite formation, incomplete penetrance	J:126359
Gapdhm2Neu/Gapdhm2Neu involves: 101/El * C3H/El	preweaning lethality, complete penetrance	J:11216, J:15476
Gapdhm3Neu/Gapdh+ C3.Cg-Gapdhm3Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
Gapdhm3Neu/Gapdh+ involves: 101/El * C3H/El	abnormal enzyme/coenzyme activity	J:15477
Gapdhm3Neu/Gapdhm3Neu C3.Cg-Gapdhm3Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
	decreased survivor rate	J:126359
	preweaning lethality, complete penetrance	J:126359
Gapdhm3Neu/Gapdhm3Neu involves: 101/El * C3H/El	abnormal enzyme/coenzyme activity	J:15477
	preweaning lethality, complete penetrance	J:11216, J:15477
Gapdhm4Neu/Gapdh+ C3.Cg-Gapdhm4Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
	preweaning lethality, incomplete penetrance	J:126359
Gapdhm4Neu/Gapdh+ involves: 101/El * C3H/El	abnormal enzyme/coenzyme activity	J:15476
Gapdhm4Neu/Gapdhm4Neu C3.Cg-Gapdhm4Neu	embryonic lethality between implantation and somite formation, incomplete penetrance	J:126359
Gapdhm4Neu/Gapdhm4Neu involves: 101/El * C3H/El	preweaning lethality, complete penetrance	J:11216, J:15476
GapdhM5Neu/Gapdh+ C3.Cg-GapdhM5Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
GapdhM5Neu/GapdhM5Neu C3.Cg-GapdhM5Neu	preweaning lethality, complete penetrance	J:126359
GapdhM6Neu/Gapdh+ C3.Cg-GapdhM6Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
	preweaning lethality, incomplete penetrance	J:126359
GapdhM6Neu/GapdhM6Neu C3.Cg-GapdhM6Neu	abnormal hematocrit	J:126359
	normal cardiovascular system phenotype	J:126359
	decreased hemoglobin content	J:126359
	normal growth/size/body region phenotype	J:126359
	normal hematopoietic system phenotype	J:126359
	normal liver/biliary system phenotype	J:126359
	preweaning lethality, complete penetrance	J:126359
	normal renal/urinary system phenotype	J:126359
GapdhM7Neu/Gapdh+ C3.Cg-GapdhM7Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
GapdhM7Neu/GapdhM7Neu C3.Cg-GapdhM7Neu	preweaning lethality, complete penetrance	J:126359
GapdhM8Neu/Gapdh+ C3.Cg-GapdhM8Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
GapdhM8Neu/GapdhM8Neu C3.Cg-GapdhM8Neu	preweaning lethality, complete penetrance	J:126359
GapdhM9Neu/Gapdh+ C3.Cg-GapdhM9Neu	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	J:126359
GapdhM9Neu/GapdhM9Neu C3.Cg-GapdhM9Neu	preweaning lethality, complete penetrance	J:126359